Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study

Télécharger : Article

Thomas Pierret, Laurent Greillier, Florian Guisier, Catherine Daniel, Renaud Descourt, Loick Galland, Olivier Molinier, Chantal Decroisette, Alexis Cortot, Diane Moreau, Laurence Bigay Game, Marie Wislez, Nicolas Cloarec, Hubert Curcio, Nicolas Delberghe, Jacques Cadranel, Boris Duchemann, Anne Claire Toffart, Christos Chouaïd, Jean-Bernard Auliac

 

Rebiopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer With EGFR/ALK/ROS Oncogenic Driver Progression After Optimal Targeted Therapy: A Multicenter Real-World Analysis

Télécharger : Article 

Antoine Bronstein, Hubert Curcio, Isabelle Monnet, Charles Ricordel, Laurence Bigay-Game, Margaux Geier, Chantal Decroisette, Catherine Daniel, Florian Guisier, Aurélie Swalduz, Anne Claire Toffart, Hélène Doubre, Jean Michel Peloni, Dominique Arpin, Hugues Morel, Remi Veillon, Benedicte Clarisse, Christos Chouaïd, Laurent Greillier, Olivier Bylicki, GFPC

 

 

Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)

Télécharger : Article 

Renaud Descourt, Florian Guisier, Maurice Pérol, Jacques Cadranel, Helene Doubre, Michael Duruisseaux, Stéphane Culine, Bertrand Mennecier, Olivier Bylicki, Christos Chouaid, Laurent Greillier

 

First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYPGFPC05-2018)

Télécharger : Article 

Romain Corre, Chantal Decroisette, Jean-Bernard Auliac, Lionel Falchero, Hubert Curcio, Karim Amrane, Maurice Perol, Stéphane Hominal, Sabine Vieillot, Eric Huchot, Anne-Laure Desage, Marie Bernardi, Remi Veillon, Hélène Doubre, Suzanna Bota, Gwenaelle Legarff, Grégoire Justeau, Oliver Bylicki, Magali Roa, Renaud Descourt, Christos Chouaïd, Laurent Greillier